Uptake of liposomally entrapped fluorescent antisense oligonucleotides in NG108-15 cells: Conventional versus pH-sensitive

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 12, 2002, Pages 1583-1587

  Skalko Basnet, Natasa ^a   Tohda, Michihisa ^a   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antisense oligonucleotide; Conventional liposome; Fluorescence activated cell sorting, confocal microscopy; NG108 15 cell; pH sensitive liposome

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHOLESTEROL HYDROGEN SUCCINATE; DEXTRAN; DIOLEOYLPHOSPHATIDYLCHOLINE; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; PHOSPHATIDYLCHOLINE; DRUG CARRIER; FLUORESCENT DYE;

ANIMAL CELL; ARTICLE; CELL LINE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG UPTAKE; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTER; GLIOMA; HYBRID CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PH; RAT; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; METABOLISM; NEUROBLASTOMA;

ANIMALS; DRUG CARRIERS; FLUORESCENT DYES; HYBRID CELLS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICE; NEUROBLASTOMA; OLIGONUCLEOTIDES, ANTISENSE; RATS; TUMOR CELLS, CULTURED;

EID: 1842870849     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1583     Document Type: Article

References (19)

1. Crooke S. T, Methods Enzymol, 313, 3-45 (2000).
2. Gewirtz A M., Stein C. A. Glazer P M, Proc. Natl. Acad Sci U.S.A, 93, 3161-3163 (1996).
3. Myers K J., Dean N. M., Trends Pharmacol. Sci, 21, 19-23 (2000).
4. Fattal E., Delattre J., Dubernet C., Couvreur P, STP Pharm Sci., 9, 383-390 (1999).
5. Couvreur P., Fattal E., Malvy C., Dubernet C., J. Liposome Res., 7, 1-18 (1997).
6. Chu C.-J., Szoka F C, J Liposome Res., 4, 361-395 (1994).
7. Chu C.-J., Dijkstra J., Lai M-Z, Hong K., Szoka F. C., Pharmacol Res, 7, 824-834 (1990).
8. Skalko N, Peschka R, Altenschmidt U, Lung A., Schubert R., FEBS Lett., 434, 351-356 (1998)
9. Tachibana R., Harashima H., Shono M, Azumano M., Niwa M., Futaki S., Kiwada H, Biochem. Biophys. Res Commun, 251, 538-544 (1998).
10. Peschka-Suss R., Skalko-Basnet N, J Liposome Res., 10, 43-59 (2000).
11. Lubrich B., van Calker D., Peschka-Suss R., Eur. J. Biochem., 267, 2432-2438 (2000).
12. Skalko-Basnet N, Tohda M., Watanabe H., Neuroreport, 11, 3117-3121 (2000).
13. Miller K. J, Das S. K., Pharm Sci. Technol Today, 1, 377-386 (1998)
14. Benimetskaya L., Tonkinson J., Stein C. A., Methods Enzymol., 313, 287-297 (2000).
15. DeOliveira M. C., Fattal E., Ropert C., Malvy C., Couvreur P., J. Control Release, 48, 179-184 (1997).
16. Crooke R. M, Graham M. J., Cooke M. E., Crooke S. T., J. Pharmacol. Exp Ther., 275, 462-473 (1995).
17. Beltinger C., Saragovi H. U., Smith R M., LeSauter L., Shah N., De-Dionisio L., Christensen L., Raible A., Jarett L., Gewirtz A. M., J. Clin. Invest., 95, 1814-1823 (1995)
18. Lai J., Crook T. J., Payne A., Lynch R. M., Porreca F., J. Pharmacol Exp. Ther, 281, 589-596 (1997).
19. Pagnan G., Stuart D. D., Pastormo F., Raffaghello L., Montaldo P G., Allen T. M., Calabretta B., Ponzoni M., J. Natl Cancer Inst., 92, 253-261 (2000).